Advisory Research Inc Castle Biosciences Inc Transaction History

Advisory Research Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$39.06 - $67.58 $483,094 - $835,829	-12,368 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$60.13 - $77.6 $443,999 - $572,998	-7,384 Reduced 37.38%	12,368 $822,000
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $108,551 - $166,459	-2,168 Reduced 9.89%	19,752 $1.45 Million
Q1 2021 May 12, 2021	BUY	$58.92 - $97.33 $467,176 - $771,729	7,929 Added 56.67%	21,920 $1.5 Million
Q4 2020 Feb 12, 2021	SELL	$43.6 - $73.05 $281,525 - $471,683	-6,457 Reduced 31.58%	13,991 $939,000
Q3 2020 Nov 12, 2020	BUY	$38.47 - $52.03 $237,744 - $321,545	6,180 Added 43.31%	20,448 $1.05 Million
Q2 2020 Aug 13, 2020	BUY	$27.28 - $43.01 $389,231 - $613,666	14,268 New	14,268 $538,000

171

25.5M

511K

130K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $750M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.